101 related articles for article (PubMed ID: 25715658)
1. Receptor-targeted lentiviral vectors are exceptionally sensitive toward the biophysical properties of the displayed single-chain Fv.
Friedel T; Hanisch LJ; Muth A; Honegger A; Abken H; Plückthun A; Buchholz CJ; Schneider IC
Protein Eng Des Sel; 2015 Apr; 28(4):93-106. PubMed ID: 25715658
[TBL] [Abstract][Full Text] [Related]
2. Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein.
Höfig I; Barth S; Salomon M; Jagusch V; Atkinson MJ; Anastasov N; Thirion C
Biomaterials; 2014 Apr; 35(13):4204-12. PubMed ID: 24529898
[TBL] [Abstract][Full Text] [Related]
3. Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.
Anastasov N; Höfig I; Mall S; Krackhardt AM; Thirion C
Methods Mol Biol; 2016; 1448():49-61. PubMed ID: 27317172
[TBL] [Abstract][Full Text] [Related]
4. [Construction and application of a lentiviral vector of single-chain variable fragment antibody against human hepatocyte growth factor receptor].
Chen Y; Guo J; Yin Y; Jiang M; Zhu H; Zhang G; Li B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):960-3. PubMed ID: 25200159
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.
Heuser C; Guhlke S; Matthies A; Bender H; Barth S; Diehl V; Abken H; Hombach A
Int J Cancer; 2004 Jun; 110(3):386-94. PubMed ID: 15095304
[TBL] [Abstract][Full Text] [Related]
6. Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.
Aires da Silva F; Costa MJ; Corte-Real S; Goncalves J
Hum Gene Ther; 2005 Feb; 16(2):223-34. PubMed ID: 15761262
[TBL] [Abstract][Full Text] [Related]
7. Generation of the single chain antibody fragment conserves the idiotypic profile of the anti-CD30 monoclonal antibody HRS3.
Hombach A; Pohl C; Heuser C; Sircar R; Koch D; Diehl V; Abken H
Scand J Immunol; 1998 Nov; 48(5):497-501. PubMed ID: 9822258
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a chimeric T-cell receptor with specificity for the Hodgkin's lymphoma-associated CD30 antigen.
Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Pohl C; Abken H
J Immunother; 1999 Nov; 22(6):473-80. PubMed ID: 10570745
[TBL] [Abstract][Full Text] [Related]
9. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
[TBL] [Abstract][Full Text] [Related]
10. Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning.
Klimka A; Matthey B; Roovers RC; Barth S; Arends JW; Engert A; Hoogenboom HR
Br J Cancer; 2000 Jul; 83(2):252-60. PubMed ID: 10901379
[TBL] [Abstract][Full Text] [Related]
11. Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.
Schlapschy M; Gruber H; Gresch O; Schäfer C; Renner C; Pfreundschuh M; Skerra A
Protein Eng Des Sel; 2004 Dec; 17(12):847-60. PubMed ID: 15708864
[TBL] [Abstract][Full Text] [Related]
12. Human microtubule-associated protein tau mediates targeted killing of CD30(+) lymphoma cells in vitro and inhibits tumour growth in vivo.
Hristodorov D; Nordlohne J; Mladenov R; Huhn M; Fischer R; Thepen T; Barth S
Br J Haematol; 2014 Jan; 164(2):251-7. PubMed ID: 24164493
[TBL] [Abstract][Full Text] [Related]
13. A new yeast display vector permitting free scFv amino termini can augment ligand binding affinities.
Wang Z; Mathias A; Stavrou S; Neville DM
Protein Eng Des Sel; 2005 Jul; 18(7):337-43. PubMed ID: 15976011
[TBL] [Abstract][Full Text] [Related]
14. Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment.
Bender RR; Muth A; Schneider IC; Friedel T; Hartmann J; Plückthun A; Maisner A; Buchholz CJ
PLoS Pathog; 2016 Jun; 12(6):e1005641. PubMed ID: 27281338
[TBL] [Abstract][Full Text] [Related]
15. Human antibodies targeting CD30(+) lymphomas.
Wezler X; Hust M; Helmsing S; Schirrmann T; Dübel S
Hum Antibodies; 2012; 21(1-2):13-28. PubMed ID: 22885957
[TBL] [Abstract][Full Text] [Related]
16. A lentiviral vector-based adenovirus fiber-pseudotyping approach for expedited functional assessment of candidate retargeted fibers.
Uil TG; de Vrij J; Vellinga J; Rabelink MJ; Cramer SJ; Chan OY; Pugnali M; Magnusson M; Lindholm L; Boulanger P; Hoeben RC
J Gene Med; 2009 Nov; 11(11):990-1004. PubMed ID: 19757488
[TBL] [Abstract][Full Text] [Related]
17. [Targeted inhibition of rabies virus replication in vitro by single chain antibody domain mediated vector expression shRNA delivery].
Yang R; Cui Y; Yang S; Wang C; Shan H; Wang H; Xia X
Wei Sheng Wu Xue Bao; 2010 Feb; 50(2):256-62. PubMed ID: 20387470
[TBL] [Abstract][Full Text] [Related]
18. Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.
Poulin KL; Lanthier RM; Smith AC; Christou C; Risco Quiroz M; Powell KL; O'Meara RW; Kothary R; Lorimer IA; Parks RJ
J Virol; 2010 Oct; 84(19):10074-86. PubMed ID: 20631131
[TBL] [Abstract][Full Text] [Related]
19. DARPins: an efficient targeting domain for lentiviral vectors.
Münch RC; Mühlebach MD; Schaser T; Kneissl S; Jost C; Plückthun A; Cichutek K; Buchholz CJ
Mol Ther; 2011 Apr; 19(4):686-93. PubMed ID: 21224833
[TBL] [Abstract][Full Text] [Related]
20. An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30.
Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Pohl C; Abken H
Cancer Res; 1998 Mar; 58(6):1116-9. PubMed ID: 9515791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
